We are a charity and rely on donations

Charity Number: 1117194 (England and Wales)

Registered Company: 06000961

Registered address:
Shift.ms, Platform, New Station Street, LS1 4JB, United Kingdom

London office:
Shift.ms, Somerset House, Strand, West Goods Entrance, London WC2R 1LA, United Kingdom

©2024 Shift.ms

@Ralee
@Ralee
 

Thanks for sharing @Stumbler

@Vixen
@Vixen
 

Yes, encouraging news with a negative twist, given that Bexarotene now won't be progressed to Stage 3 trials. However, it is now beyond doubt that remyelination is possible which is a huge step forward. Let's keep watching and waiting @stumbler....